Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
is a medicinal herb with a diverse range of chemotypes that can exert both anxiolytic and anxiogenic effects on humans. Medical cannabis patients receiving organically grown cannabis from a single source were surveyed about the effectiveness of cannabis for treating anxiety. Patients rated cannabis as highly effective overall for treating anxiety with an average score of 8.03 on a Likert scale of 0 to 10 (0 = not effective, 10 = extremely effective). Patients also identified which strains they found the most or least effective for relieving their symptoms of anxiety. To find correlations between anxiolytic activity and chemotype, the top four strains voted most and least effective were analyzed by HPLC-MS/MS to quantify cannabinoids and GC-MS to quantify terpenes. Tetrahydrocannabinol (THC) and trans-nerolidol have statistically significant correlations with increased anxiolytic activity. Guiaol, eucalyptol, γ-terpinene, α-phellandrene, 3-carene, and sabinene hydrate all have significant correlations with decreased anxiolytic activity. Further studies are needed to better elucidate the entourage effects that contribute to the anxiolytic properties of cannabis varieties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Habitat fragmentation and its lasting impact on Earth’s ecosystems
Haddad, N. M., Brudvig, L. A., Clobert, J., Davies, K. F., Gonzalez, A., Holt, R. D., Lovejoy, T. E., Sexton, J. O., Austin, M. P., Collins, C. D., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500052 · Cited by 4,773 · cited 1×
“The widespread reductionist philosophy has made our scientific, social, and even ecological landscapes increasingly fragmented over the past century (Watson, 1971; Haddad et al., 2015).”
BackgroundThe biodiversity of species and their rates of extinction, distribution, and protection
Pimm, S. L., Jenkins, C. N., Abell, R., Brooks, T. M., Gittleman, J. L., Joppa, L. N., Raven, P. H., Roberts, C. M., & Sexton, J. O. (2014) · Science · doi:10.1126/science.1246752 · Cited by 3,542 · cited 1×
“and habitat destruction (Díaz et al., 2006; Pimm et al., 2014), threatening the health of future generations (Díaz et al.”
BackgroundThe Effects of Climate Change on Cardiac Health
De Blois, J., Kjellstrom, T., Agewall, S., Ezekowitz, J. A., Armstrong, P. W., & Atar, D. (2015) · Cardiology · doi:10.1159/000398787 · Cited by 1,697
Biodiversity loss threatens human well-being
Díaz, S., Fargione, J., Chapin, F. S., & Tilman, D. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040277 · Cited by 1,544
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory.
Barlow, D. H. (2000) · American Psychologist · doi:10.1037/0003-066x.55.11.1247 · Cited by 1,135
Climate change and mental health: a causal pathways framework
Berry, H. L., Bowen, K., & Kjellstrom, T. (2010) · International Journal of Public Health · doi:10.1007/s00038-009-0112-0 · Cited by 1,035 · cited 1×
“Climate change is already associated with increased stress and anxiety, and this is only projected to increase with crop failures, economic perturbations, and habitat destruction (Fritze et al., 2008; Berry et al., 2010).”
BackgroundPhytocannabinoids: a unified critical inventory
Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2016) · Natural Product Reports · doi:10.1039/c6np00074f · Cited by 844 · cited 1×
“Phytocannabinoids are a diverse group of over 150 terpenoid compounds and the most abundant secondary plant metabolites produced by the cannabis plant (Hanuš et al., 2016).”
BackgroundBergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771 · cited 1×
“Furthermore, preclinical evidence suggests that CBD possesses both anxiolytic and antipsychotic properties (Guimarães et al., 1990; Bergamaschi et al., 2011).”
BackgroundHope, despair and transformation: Climate change and the promotion of mental health and wellbeing
Fritze, J. G., Blashki, G. A., Burke, S., & Wiseman, J. (2008) · International Journal of Mental Health Systems · doi:10.1186/1752-4458-2-13 · Cited by 602
The draft genome and transcriptome of Cannabis sativa.
van Bakel, H., Stout, J. M., Cote, A. G., Tallon, C. M., Sharpe, A. G., Hughes, T. R., & Page, J. E. (2011) · Genome Biology · doi:10.1186/gb-2011-12-10-r102 · Cited by 575 · cited 1×
“This resulted in “landrace” varieties with diverse chemotypes adapted to local ecosystems (Hillig, 2005; Warf, 2014).”
BackgroundGenome-wide epigenetic regulation by early-life trauma
Labonté, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., Bureau, A., Mechawar, N., Szyf, M., Meaney, M. J., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2287 · Cited by 488 · cited 1×
“Recent epigenetic research has demonstrated that early life traumatic events leave lasting changes to the epigenome, and there are even significant differences in DNA-methylation patterns between different socio-economic classes (Labonté et al., 2012; McGuinness et al., 2012).”
BackgroundConstructing drug effects: a history of set and setting
Hartogsohn, I. (2017) · Drug Science Policy and Law · doi:10.1177/2050324516683325 · Cited by 472 · cited 1×
“More than just molecular interactions must be considered as the “set and setting,” which refers to the mindset of the user along with their physical and social environment, affects the individual’s response to psychoactive drugs (Hartogsohn, 2017).”
BackgroundFusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Antianxiety effect of cannabidiol in the elevated plus-maze
Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · cited 2×
“Furthermore, preclinical evidence suggests that CBD possesses both anxiolytic and antipsychotic properties (Guimarães et al., 1990; Bergamaschi et al., 2011).”
BackgroundEffects of cannabidiol (CBD) on regional cerebral blood flow
Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307
Notcutt, W., Price, M., Miller, R., Newport, S., Phillips, C., Simmons, S., & Sansom, C. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03674.x · Cited by 305 · cited 1×
“Cannabis is becoming increasingly researched and recognized for the treatment of many health conditions including anxiety, stress, depression, and pain (Notcutt et al., 2004; Andreae et al., 2015).”
BackgroundBahi, A., Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S. M., & Ojha, S. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.06.003 · Cited by 291
Hill, M. N., Bierer, L. M., Makotkine, I., Golier, J. A., Galea, S., McEwen, B. S., Hillard, C. J., & Yehuda, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.08.004 · Cited by 256 · cited 1×
“Likewise, peripheral concentrations of anandamide in PTSD patients have been shown to be inversely correlated with symptom severity (Hill et al., 2013).”
BackgroundAcute stress increases circulating anandamide and other N-acylethanolamines in healthy humans
Dlugos, A., Childs, E., Stuhr, K. L., Hillard, C. J., & de Wit, H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.100 · Cited by 248 · cited 1×
“Moreover, baseline anxiety is also inversely correlated with peripheral AEA concentrations in healthy adult individuals (Dlugos et al., 2012).”
BackgroundThe endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233
Effects of citrus fragrance on immune function and depressive states.
Komori, T., Fujiwara, R., Tanida, M., Nomura, J., & Yokoyama, M. M. (1995) · Neuroimmunomodulation · doi:10.1159/000096889 · Cited by 224
Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., & Brenneisen, R. (2003) · Pain · doi:10.1016/s0304-3959(03)00163-5 · Cited by 209 · cited 1×
“Interestingly, synthetic THC (Dronabinol) which has been approved to treat pain, exhibits anxiety as a common side effect (Naef et al., 2003).”
BackgroundSocio-economic status is associated with epigenetic differences in the pSoBid cohort
McGuinness, D., McGlynn, L. M., Johnson, P. C., MacIntyre, A., Batty, G. D., Burns, H., Cavanagh, J., Deans, K. A., Ford, I., McConnachie, A., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr215 · Cited by 193
Pamplona, F. A., da Silva, L. R., & Coan, A. C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00759 · Cited by 190
The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety
FABRE, L. F., & McLENDON, D. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02617.x · Cited by 138 · cited 1×
“Clinical trials have shown Nabilone, a synthetic THC analog and CB1 agonist, to be effective in the treatment of anxiety (Fabre and McLendon, 1981).”
BackgroundSoares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112 · cited 1×
“In rat models of generalized anxiety, micro-injections of CBD in the dorsal periaqueductal gray is shown to produce anxiolytic effects via partial activation of the Serotonin 1A Receptor (5-HT1A) receptors (Bitencourt et al., 2008; Soares et al., 2010).”
Background
Cited by
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2409-8 · Cited by 253
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Aran, A., Harel, M., Cassuto, H., Polyansky, L., Schnapp, A., Wattad, N., Shmueli, D., Golan, D., & Castellanos, F. X. (2021) · Molecular Autism · doi:10.1186/s13229-021-00420-2 · Cited by 223
“These components have also been reported to impact human behaviour [27, 28].”
Background
Metadata
- Authors
- Kamal, B. S., Kamal, F., & Lantela, D. E.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-10-22
- Volume
- 12
- Pages
- 730-730
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2897650757
- Cited by
- 55
- References
- 27
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.